Search Results - "VIGNALI, Dario A. A"

Refine Results
  1. 1

    Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups by Andrews, Lawrence P., Yano, Hiroshi, Vignali, Dario A. A.

    Published in Nature immunology (01-11-2019)
    “…Although immunotherapeutics targeting the inhibitory receptors (IRs) CTLA-4, PD-1 or PD-L1 have made substantial clinical progress in cancer, a considerable…”
    Get full text
    Journal Article
  2. 2

    Interferon-γ: teammate or opponent in the tumour microenvironment? by Gocher, Angela M., Workman, Creg J., Vignali, Dario A. A.

    Published in Nature reviews. Immunology (01-03-2022)
    “…Cancer immunotherapy offers substantive benefit to patients with various tumour types, in some cases leading to complete tumour clearance. However, many…”
    Get full text
    Journal Article
  3. 3

    LAG-3 as the third checkpoint inhibitor by Aggarwal, Vaishali, Workman, Creg J., Vignali, Dario A. A.

    Published in Nature immunology (01-09-2023)
    “…Lymphocyte activation gene 3 (LAG-3) is an inhibitory receptor that is highly expressed by exhausted T cells. LAG-3 is a promising immunotherapeutic target,…”
    Get full text
    Journal Article
  4. 4

    LAG3 (CD223) as a cancer immunotherapy target by Andrews, Lawrence P., Marciscano, Ariel E., Drake, Charles G., Vignali, Dario A. A.

    Published in Immunological reviews (01-03-2017)
    “…Summary Despite the impressive impact of CTLA4 and PD1‐PDL1‐targeted cancer immunotherapy, a large proportion of patients with many tumor types fail to…”
    Get full text
    Journal Article
  5. 5

    Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer by Cillo, Anthony R., Kürten, Cornelius H.L., Tabib, Tracy, Qi, Zengbiao, Onkar, Sayali, Wang, Ting, Liu, Angen, Duvvuri, Umamaheswar, Kim, Seungwon, Soose, Ryan J., Oesterreich, Steffi, Chen, Wei, Lafyatis, Robert, Bruno, Tullia C., Ferris, Robert L., Vignali, Dario A.A.

    Published in Immunity (Cambridge, Mass.) (14-01-2020)
    “…Head and neck squamous cell carcinoma (HNSCC) arises through exposure to environmental carcinogens or malignant transformation by human papillomavirus (HPV)…”
    Get full text
    Journal Article
  6. 6

    How regulatory T cells work by Vignali, Dario A. A, Collison, Lauren W, Workman, Creg J

    Published in Nature reviews. Immunology (01-07-2008)
    “…Key Points Regulatory T (T Reg ) cells are essential for maintaining peripheral tolerance, preventing autoimmunity and limiting chronic inflammatory diseases…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity by Liu, Chang, Somasundaram, Ashwin, Manne, Sasikanth, Gocher, Angela M., Szymczak-Workman, Andrea L., Vignali, Kate M., Scott, Ellen N., Normolle, Daniel P., John Wherry, E., Lipson, Evan J., Ferris, Robert L., Bruno, Tullia C., Workman, Creg J., Vignali, Dario A. A.

    Published in Nature immunology (01-09-2020)
    “…Robust CD8 + T cell memory is essential for long-term protective immunity but is often compromised in cancer, where T cell exhaustion leads to loss of memory…”
    Get full text
    Journal Article
  9. 9

    Once a Treg, always a Treg? by Sawant, Deepali V., Vignali, Dario A. A.

    Published in Immunological reviews (01-05-2014)
    “…Summary Regulatory T cells (Tregs) prevail as a specialized cell lineage that has a central role in the dominant control of immunological tolerance and…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    LAG3 associates with TCR–CD3 complexes and suppresses signaling by driving co-receptor–Lck dissociation by Guy, Clifford, Mitrea, Diana M., Chou, Po-Chien, Temirov, Jamshid, Vignali, Kate M., Liu, Xueyan, Zhang, Hui, Kriwacki, Richard, Bruchez, Marcel P., Watkins, Simon C., Workman, Creg J., Vignali, Dario A. A.

    Published in Nature immunology (01-05-2022)
    “…LAG3 is an inhibitory receptor that is highly expressed on exhausted T cells. Although LAG3-targeting immunotherapeutics are currently in clinical trials, how…”
    Get full text
    Journal Article
  14. 14

    Inhibitory receptors as targets for cancer immunotherapy by Turnis, Meghan E., Andrews, Lawrence P., Vignali, Dario A. A.

    Published in European journal of immunology (01-07-2015)
    “…Inhibitory receptors expressed on T cells control immune responses while limiting autoimmunity. However, tumors can hijack these “checkpoints” for protection…”
    Get full text
    Journal Article
  15. 15

    Co-stimulatory and Co-inhibitory Pathways in Autoimmunity by Zhang, Qianxia, Vignali, Dario A.A.

    Published in Immunity (Cambridge, Mass.) (17-05-2016)
    “…The immune system is guided by a series of checks and balances, a major component of which is a large array of co-stimulatory and co-inhibitory pathways that…”
    Get full text
    Journal Article
  16. 16

    The inhibitory cytokine IL-35 contributes to regulatory T-cell function by COLLISON, Lauren W, WORKMAN, Creg J, KUO, Timothy T, BOYD, Kelli, YAO WANG, VIGNALI, Kate M, CROSS, Richard, SEHY, David, BLUMBERG, Richard S, VIGNALI, Dario A. A

    Published in Nature (22-11-2007)
    “…Regulatory T (T(reg)) cells are a critical sub-population of CD4+ T cells that are essential for maintaining self tolerance and preventing autoimmunity, for…”
    Get full text
    Journal Article
  17. 17

    Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung by Faustino, Lucas D., Griffith, Jason W., Rahimi, Rod A., Nepal, Keshav, Hamilos, Daniel L., Cho, Josalyn L., Medoff, Benjamin D., Moon, James J., Vignali, Dario A. A., Luster, Andrew D.

    Published in Nature immunology (01-11-2020)
    “…Foxp3 + regulatory T (T reg ) cells expressing the interleukin (IL)-33 receptor ST2 mediate tissue repair in response to IL-33. Whether T reg cells also…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Targeting regulatory T cells in tumors by Liu, Chang, Workman, Creg J., Vignali, Dario A. A.

    Published in The FEBS journal (01-07-2016)
    “…Regulatory T (Treg) cells play a crucial role in maintaining peripheral tolerance and preventing autoimmunity. However, they also represent a major barrier to…”
    Get full text
    Journal Article
  20. 20

    development and function of regulatory T cells by Workman, Creg J, Szymczak-Workman, Andrea L, Collison, Lauren W, Pillai, Meenu R, Vignali, Dario A. A

    “…Regulatory T cells (Tregs) are a critical subset of T cells that mediate peripheral tolerance. There are two types of Tregs: natural Tregs, which develop in…”
    Get full text
    Journal Article